Vancomycin-resistant Staphylococcus aureus laboratory findings
Vancomycin-resistant Staphylococcus aureus Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Vancomycin-resistant Staphylococcus aureus laboratory findings On the Web |
American Roentgen Ray Society Images of Vancomycin-resistant Staphylococcus aureus laboratory findings |
FDA on Vancomycin-resistant Staphylococcus aureus laboratory findings |
CDC on Vancomycin-resistant Staphylococcus aureus laboratory findings |
Vancomycin-resistant Staphylococcus aureus laboratory findings in the news |
Blogs on Vancomycin-resistant Staphylococcus aureus laboratory findings |
Directions to Hospitals Treating Vancomycin-resistant Staphylococcus aureus |
Risk calculators and risk factors for Vancomycin-resistant Staphylococcus aureus laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Staph bacteria are classified as VISA or VRSA based on laboratory tests. Laboratories perform tests to determine if staph bacteria are resistant to antimicrobial agents that might be used for treatment of infections. For vancomycin and other antimicrobial agents, laboratories determine how much of the agent it requires to inhibit the growth of the organism in a test tube. The result of the test is usually expressed as a minimum inhibitory concentration (MIC) or the minimum amount of antimicrobial agent that inhibits bacterial growth in the test tube. Therefore, staph bacteria are classified as VISA if the MIC for vancomycin is 4-8µg/ml, and classified as VRSA if the vancomycin MIC is >16µg/ml.